ResMed Inc (RSMDF) stock
RSMDFOTCSurgical & Medical Instruments & ApparatusFiscal year ends June 30Also trades as RMD
Financials through Q4 FY2026, quarter ended Jun 30, 2026Last filing: 10-K on Aug 13, 2026Score 21/3011% below fair value
$22.61+0.00 (0.00%)
Close on Oct 19, 2026Market cap $33.17BP/E 22.0Yield 1.04%
ResMed operating margin
Operating margin is operating income as a percentage of revenue.
ResMed's operating margin for the twelve months ending Jun 30, 2026 was 33.4%. For fiscal 2026 it was 33.4%, against 32.7% the year before. The highest annual figure on record is 33.4% in fiscal 2026.
Annual operating margin
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| FY2026 | Jun 30, 2026 | 33.4% | +0.6 |
| FY2025 | Jun 30, 2025 | 32.7% | +4.6 |
| FY2024 | Jun 30, 2024 | 28.2% | +1.4 |
| FY2023 | Jun 30, 2023 | 26.8% | −1.2 |
| FY2022 | Jun 30, 2022 | 28.0% | −0.3 |
| FY2021 | Jun 30, 2021 | 28.3% | +0.9 |
| FY2020 | Jun 30, 2020 | 27.4% | +5.2 |
| FY2019 | Jun 30, 2019 | 22.2% | −0.9 |
| FY2018 | Jun 30, 2018 | 23.2% | +2.6 |
| FY2017 | Jun 30, 2017 | 20.6% | −2.7 |
| FY2016 | Jun 30, 2016 | 23.3% | −1.0 |
| FY2015 | Jun 30, 2015 | 24.4% | −1.7 |
| FY2014 | Jun 30, 2014 | 26.1% | +2.6 |
| FY2013 | Jun 30, 2013 | 23.4% | +1.9 |
| FY2012 | Jun 30, 2012 | 21.5% | +0.0 |
| FY2011 | Jun 30, 2011 | 21.5% | −0.5 |
| FY2010 | Jun 30, 2010 | 22.0% | +1.3 |
| FY2009 | Jun 30, 2009 | 20.7% | – |
Quarterly operating margin
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| Q4 FY2026 | Jun 30, 2026 | 30.7% | −3.1 |
| Q3 FY2026 | Mar 31, 2026 | 34.9% | +1.9 |
| Q2 FY2026 | Dec 31, 2025 | 34.6% | +2.0 |
| Q1 FY2026 | Sep 30, 2025 | 33.4% | +1.8 |
| Q4 FY2025 | Jun 30, 2025 | 33.7% | +2.6 |
| Q3 FY2025 | Mar 31, 2025 | 33.0% | +1.7 |
| Q2 FY2025 | Dec 31, 2024 | 32.5% | +8.9 |
| Q1 FY2025 | Sep 30, 2024 | 31.6% | +5.4 |
| Q4 FY2024 | Jun 30, 2024 | 31.2% | +6.6 |
| Q3 FY2024 | Mar 31, 2024 | 31.3% | +4.4 |
| Q2 FY2024 | Dec 31, 2023 | 23.7% | −3.4 |
| Q1 FY2024 | Sep 30, 2023 | 26.2% | −2.8 |
| Q4 FY2023 | Jun 30, 2023 | 24.5% | −3.4 |
| Q3 FY2023 | Mar 31, 2023 | 26.9% | −0.2 |
| Q2 FY2023 | Dec 31, 2022 | 27.1% | −0.7 |
| Q1 FY2023 | Sep 30, 2022 | 29.0% | +0.0 |
| Q4 FY2022 | Jun 30, 2022 | 27.9% | +0.3 |
| Q3 FY2022 | Mar 31, 2022 | 27.1% | −2.0 |
| Q2 FY2022 | Dec 31, 2021 | 27.8% | +0.1 |
| Q1 FY2022 | Sep 30, 2021 | 29.0% | +0.1 |
| Q4 FY2021 | Jun 30, 2021 | 27.6% | −1.4 |
| Q3 FY2021 | Mar 31, 2021 | 29.1% | +0.8 |
| Q2 FY2021 | Dec 31, 2020 | 27.7% | +0.8 |
| Q1 FY2021 | Sep 30, 2020 | 28.8% | +3.7 |
| Q4 FY2020 | Jun 30, 2020 | 29.0% | +11.8 |
| Q3 FY2020 | Mar 31, 2020 | 28.3% | +4.6 |
| Q2 FY2020 | Dec 31, 2019 | 26.9% | +2.7 |
| Q1 FY2020 | Sep 30, 2019 | 25.1% | +0.6 |
| Q4 FY2019 | Jun 30, 2019 | 17.2% | −6.4 |
| Q3 FY2019 | Mar 31, 2019 | 23.7% | +0.7 |
| Q2 FY2019 | Dec 31, 2018 | 24.1% | −0.2 |
| Q1 FY2019 | Sep 30, 2018 | 24.5% | +3.0 |
| Q4 FY2018 | Jun 30, 2018 | 23.6% | +0.7 |
| Q3 FY2018 | Mar 31, 2018 | 23.1% | +2.2 |
| Q2 FY2018 | Dec 31, 2017 | 24.3% | +6.0 |
| Q1 FY2018 | Sep 30, 2017 | 21.5% | +1.3 |
| Q4 FY2017 | Jun 30, 2017 | 22.9% | – |
| Q3 FY2017 | Mar 31, 2017 | 20.9% | – |
| Q2 FY2017 | Dec 31, 2016 | 18.3% | – |
| Q1 FY2017 | Sep 30, 2016 | 20.2% | – |